147 related articles for article (PubMed ID: 10648636)
1. Molecular determinants of mexiletine structure for potent and use-dependent block of skeletal muscle sodium channels.
De Luca A; Natuzzi F; Desaphy JF; Loni G; Lentini G; Franchini C; Tortorella V; Camerino DC
Mol Pharmacol; 2000 Feb; 57(2):268-77. PubMed ID: 10648636
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of skeletal muscle sodium currents by mexiletine analogues: specific hydrophobic interactions rather than lipophilia per se account for drug therapeutic profile.
De Luca A; Talon S; De Bellis M; Desaphy JF; Franchini C; Lentini G; Catalano A; Corbo F; Tortorella V; Conte-Camerino D
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):318-27. PubMed ID: 12644906
[TBL] [Abstract][Full Text] [Related]
3. Optically active mexiletine analogues as stereoselective blockers of voltage-gated Na(+) channels.
Franchini C; Carocci A; Catalano A; Cavalluzzi MM; Corbo F; Lentini G; Scilimati A; Tortorella P; Camerino DC; De Luca A
J Med Chem; 2003 Nov; 46(24):5238-48. PubMed ID: 14613326
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide.
De Luca A; Natuzzi F; Falcone G; Duranti A; Lentini G; Franchini C; Tortorella V; Camerino DC
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):777-87. PubMed ID: 9453464
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers.
De Luca A; Natuzzi F; Lentini G; Franchini C; Tortorella V; Conte Camerino D
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):653-61. PubMed ID: 9053738
[TBL] [Abstract][Full Text] [Related]
6. New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse.
De Luca A; Pierno S; Liantonio A; Desaphy JF; Natuzzi F; Didonna MP; Ferrannini E; Jockusch H; Franchini C; Lentini G; Corbo F; Tortorella V; Camerino DC
Neuromuscul Disord; 2004 Jul; 14(7):405-16. PubMed ID: 15210163
[TBL] [Abstract][Full Text] [Related]
7. Homologation of mexiletine alkyl chain and stereoselective blockade of skeletal muscle sodium channels.
Duranti A; Franchini C; Lentini G; Loiodice F; Tortorella V; De Luca A; Pierno S; Conte Camerino D
Eur J Med Chem; 2000 Jan; 35(1):147-56. PubMed ID: 10733611
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro sodium channel blocking activity evaluation of novel homochiral mexiletine analogs.
Carocci A; Catalano A; Bruno C; Lentini G; Franchini C; De Bellis M; De Luca A; Conte Camerino D
Chirality; 2010 Mar; 22(3):299-307. PubMed ID: 19544349
[TBL] [Abstract][Full Text] [Related]
9. Stereospecific synthesis of "para-hydroxymexiletine" and sodium channel blocking activity evaluation.
Catalano A; Carocci A; Fracchiolla G; Franchini C; Lentini G; Tortorella V; De Luca A; De Bellis M; Desaphy JF; Conte Camerino D
Chirality; 2004 Feb; 16(2):72-8. PubMed ID: 14712469
[TBL] [Abstract][Full Text] [Related]
10. Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo.
Talon S; De Luca A; De Bellis M; Desaphy JF; Lentini G; Scilimati A; Corbo F; Franchini C; Tortorella P; Jockusch H; Conte Camerino D
Br J Pharmacol; 2001 Dec; 134(7):1523-31. PubMed ID: 11724759
[TBL] [Abstract][Full Text] [Related]
11. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation.
Aoike F; Takahashi MP; Sakoda S
Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348
[TBL] [Abstract][Full Text] [Related]
12. Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX.
Desaphy JF; Conte Camerino D; Franchini C; Lentini G; Tortorella V; De Luca A
Br J Pharmacol; 1999 Nov; 128(6):1165-74. PubMed ID: 10578128
[TBL] [Abstract][Full Text] [Related]
13. Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access.
Sasaki K; Makita N; Sunami A; Sakurada H; Shirai N; Yokoi H; Kimura A; Tohse N; Hiraoka M; Kitabatake A
Mol Pharmacol; 2004 Aug; 66(2):330-6. PubMed ID: 15266024
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the antimyotonic activity of mexiletine and some new analogs on sodium currents of single muscle fibers and on the abnormal excitability of the myotonic ADR mouse.
De Luca A; Pierno S; Natuzzi F; Franchini C; Duranti A; Lentini G; Tortorella V; Jockusch H; Camerino DC
J Pharmacol Exp Ther; 1997 Jul; 282(1):93-100. PubMed ID: 9223544
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the pharmacological activity of the major mexiletine metabolites on skeletal muscle sodium currents.
De Bellis M; De Luca A; Rana F; Cavalluzzi MM; Catalano A; Lentini G; Franchini C; Tortorella V; Conte Camerino D
Br J Pharmacol; 2006 Oct; 149(3):300-10. PubMed ID: 16921388
[TBL] [Abstract][Full Text] [Related]
16. Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential.
De Bellis M; Sanarica F; Carocci A; Lentini G; Pierno S; Rolland JF; Conte Camerino D; De Luca A
Front Pharmacol; 2017; 8():907. PubMed ID: 29379434
[TBL] [Abstract][Full Text] [Related]
17. Combined modifications of mexiletine pharmacophores for new lead blockers of Na(v)1.4 channels.
De Bellis M; De Luca A; Desaphy JF; Carbonara R; Heiny JA; Kennedy A; Carocci A; Cavalluzzi MM; Lentini G; Franchini C; Camerino DC
Biophys J; 2013 Jan; 104(2):344-54. PubMed ID: 23442856
[TBL] [Abstract][Full Text] [Related]
18. Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+ channels.
Wang GK; Russell C; Wang SY
J Physiol; 2004 Feb; 554(Pt 3):621-33. PubMed ID: 14608007
[TBL] [Abstract][Full Text] [Related]
19. NA+- and K+-channels as molecular targets of the alkaloid ajmaline in skeletal muscle fibres.
Friedrich O; V Wegner F; Wink M; Fink RH
Br J Pharmacol; 2007 May; 151(1):82-93. PubMed ID: 17351660
[TBL] [Abstract][Full Text] [Related]
20. Hydroxylated analogs of mexiletine as tools for structural-requirements investigation of the sodium channel blocking activity.
Catalano A; Carocci A; Cavalluzzi MM; Di Mola A; Lentini G; Lovece A; Dipalma A; Costanza T; Desaphy JF; Conte Camerino D; Franchini C
Arch Pharm (Weinheim); 2010 Jun; 343(6):325-32. PubMed ID: 20509146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
